Search Results - "Maraveyas, A."

Tissue factor‐bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancer by Date, K., Ettelaie, C., Maraveyas, A.

“…Summary Cancer is associated with an increased risk of venous thromboembolism (VTE); the exact mechanisms for the induction of VTE remain to be fully…”
Get full text

Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline by Falanga, A., Ay, C., Di Nisio, M., Gerotziafas, G., Jara-Palomares, L., Langer, F., Lecumberri, R., Mandala, M., Maraveyas, A., Pabinger, I., Sinn, M., Syrigos, K., Young, A., Jordan, K.

“…•Cancer-associated thrombosis is a major health problem that affects morbidity and mortality of people with cancer.•Surgical and systemic pharmacological…”
Get full text

Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control by Glynne-Jones, R., Counsell, N., Quirke, P., Mortensen, N., Maraveyas, A., Meadows, H.M., Ledermann, J., Sebag-Montefiore, D.

“…In stage III colon cancer, oxaliplatin/5-fluorouracil (5-FU)-based adjuvant chemotherapy (FOLFOX) improves disease-free survival (DFS) and overall survival…”
Get full text

Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer by Maraveyas, A, Waters, J, Roy, R, Fyfe, D, Propper, D, Lofts, F, Sgouros, J, Gardiner, E, Wedgwood, K, Ettelaie, C, Bozas, G

“…Abstract Background Annualised figures show an up to 7-fold higher incidence of vascular thromboembolism (VTE) in patients with advanced pancreatic cancer…”
Get full text

Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study by Valle, J W, Wasan, H, Johnson, P, Jones, E, Dixon, L, Swindell, R, Baka, S, Maraveyas, A, Corrie, P, Falk, S, Gollins, S, Lofts, F, Evans, L, Meyer, T, Anthoney, A, Iveson, T, Highley, M, Osborne, R, Bridgewater, J

“…Background: We assessed the activity of gemcitabine (G) and cisplatin/gemcitabine (C/G) in patients with locally advanced (LA) or metastatic (M) (advanced)…”
Get full text

Risk of recurrent venous thromboembolism and major hemorrhage in cancer‐associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 patients by Hulle, T., Exter, P. L., Planquette, B., Meyer, G., Soler, S., Monreal, M., Jiménez, D., Portillo, A. K., O'Connell, C., Liebman, H. A., Shteinberg, M., Adir, Y., Tiseo, M., Bersanelli, M., Abdel‐Razeq, H. N., Mansour, A. H., Donnelly, O. G., Radhakrishna, G., Ramasamy, S., Bozas, G., Maraveyas, A., Shinagare, A. B., Hatabu, H., Nishino, M., Huisman, M. V., Klok, F. A.

“…Essentials We performed a pooled analysis of 926 patients with cancer‐associated incidental pulmonary embolism (IPE). Vitamin K antagonists (VKA) are…”
Get full text

Microparticle-associated tissue factor is recycled by endothelial cells resulting in enhanced surface tissue factor activity by Collier, M E W, Mah, P-M, Xiao, Y, Maraveyas, A, Ettelaie, C

“…In this study the uptake of tissue factor (TF)-positive microparticles by endothelial cells and the recycling of the TF component were examined. Human dermal…”
Get more information

Does clinical method mask significant VTE-related mortality and morbidity in malignant disease? by Maraveyas, A, Johnson, M

“…After more than 150 years of a recognised link between cancer and vascular thromboembolic events (VTE), and despite a greatly improved understanding of its…”
Get full text

PO-27 - Thrombin generation in pancreatic cancer and multiple myeloma with use of calibrated automated thrombography by Adesanya, M.A, Maraveyas, A, Madden, L.A

“…Introduction The calibrated automated thrombography (CAT) assay is emerging as a reliable tool for real time estimation of thrombin generation (TG) potential…”
Get full text

PO-39 - Primary thromboprophylaxis for ambulatory patients with advanced metastatic pancreatic cancer. A practical implementation of lessons from published experience by Bozas, G, Muazzam, I.A, Ilyas, W, Maraveyas, A

“…Introduction The efficacy and safety of primary prophylaxis in advanced pancreatic cancer (APC) has been demonstrated in randomized controlled studies. Current…”
Get full text

Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy by MANTON, D. J, CHATURVEDI, A, HUBBARD, A, LIND, M. J, LOWRY, M, MARAVEYAS, A, PICKLES, M. D, TOZER, D. J, TURNBULL, L. W

“…A prospective study was undertaken in women undergoing neoadjuvant chemotherapy for locally advanced breast cancer in order to determine the ability of…”
Get full text

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial by Corrie, P.G., Marshall, A., Nathan, P.D., Lorigan, P., Gore, M., Tahir, S., Faust, G., Kelly, C.G., Marples, M., Danson, S.J., Marshall, E., Houston, S.J., Board, R.E., Waterston, A.M., Nobes, J.P., Harries, M., Kumar, S., Goodman, A., Dalgleish, A., Martin-Clavijo, A., Westwell, S., Casasola, R., Chao, D., Maraveyas, A., Patel, P.M., Ottensmeier, C.H., Farrugia, D., Humphreys, A., Eccles, B., Young, G., Barker, E.O., Harman, C., Weiss, M., Myers, K.A., Chhabra, A., Rodwell, S.H., Dunn, J.A., Middleton, M.R.

Get full text

PO-30 - Changes in soluble CD106 and CD54 serum levels during chemotherapy treatment for multiple myeloma by Hall, J, Adesanya, M.A, Madden, L.A, Maraveyas, A

“…Introduction IMiD-based regimens are now widely considered standard of care in the treatment of Multiple myeloma (MM) patients (Kumar et al., 2008). One of the…”
Get full text

Osteonecrosis of the jaw in patients treated with sunitinib and zoledronic acid by Bozas, G., Allgar, V., Greenwood, G., Maraveyas, A.

“…Abstract only…”
Get full text

Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY study by Lorigan, P., Marples, M., Harries, M., Wagstaff, J., Dalgleish, A.G., Osborne, R., Maraveyas, A., Nicholson, S., Davidson, N., Wang, Q., Pericleous, L., Bapat, U., Middleton, M.R.

“…Summary Background Advanced melanoma is an aggressive disease with a poor prognosis. Approved therapy is limited in the U.K. and, until recently, no treatment…”
Get full text

Neoadjuvant Chemoradiotherapy for Resectable Oesophageal and Gastro-oesophageal Junction Cancer—Do We Need Another Randomised Trial? by Hingorani, M, Crosby, T, Maraveyas, A, Dixit, S, Bateman, A, Roy, R

“…Abstract Aims The optimal neoadjuvant therapy option for locally advanced oesophageal cancer remains elusive. Neoadjuvant chemoradiotherapy (CRT) is the…”
Get full text

Tissue factor expression determines tumour cell coagulation kinetics by WELSH, J., SMITH, J. D., YATES, K. R., GREENMAN, J., MARAVEYAS, A., MADDEN, L. A.

“…Summary Introduction:  Cancers are associated with varying degrees of an increased risk of venous thromboembotic events (VTE) occurring. This increased risk is…”
Get full text

Effect of resection of localized pancreaticobiliary adenocarcinoma on angiogenic markers and tissue factor related pro-thrombotic and pro-angiogenic activity by Echrish, H.H, Xiao, Y, Madden, L.A, Allgar, V, Cooke, J, Wedgwood, K, Dasgupta, D, Greenman, J, Maraveyas, A

“…Abstract In this study, 52 patients were studied to elucidate the relative impact of resection of localized pancreaticobiliary adenocarcinoma (PBC) on…”
Get full text

A pulmonary severity index (PESI)-based competency that underpins a modular outpatient nurse lead PE (pulmonary embolism) service for cancer patients by Palmer, J, Bozas, G, Avery, G, Stephens, A, Maraveyas, A

Get full text

Testing for and treating cancer associated thrombosis: choice of anticoagulant by Johnson, M.J, Sheard, L, Noble, S, Maraveyas, A, Prout, H, Watt, I, Dowding, D

Get full text